Others 8

Others 8

Others 8 related products

Structure Cat No. Product Name CAS No. Product Description
V3608 Echinocandin B 54651-05-7 Echinocandin B is a novel and potent cyclic hexapeptide echinocandin antibioticoriginallyisolated from Aspergillus nidulans var.
V3855 Ehp-inhibitor 861249-77-6 Ehp inhibitor is a novel and potent inhibitor of EHP.
V3611 Enantiomer of Sofosbuvir Enantiomer of Sofosbuvir is the isomer/enantiomer of Sofosbuvir(also known as PSI-7977, GS-7977; tradenames Sovaldi and Virunon) is a HCV NS5B polymerase inhibitor that is used for the treatment of chronic hepatitis C virus (HCV) infection.
V3618 Epelsiban 872599-83-2 Epelsiban (also known asGSK557296; GSK-557296) is a novel, potent, selective and orally bioavailableoxytocin receptorantagonist, with apKiof 9.9 for human oxytocin receptor.
V3638 Epetraborole R-Mandelate 1234563-15-5 Epetraborole R-Mandelate (also known as GSK2251052 and AN3365) is a novel, potent and selective leucyl-tRNA synthetase (LeuRS) inhibitor, which inhibits protein synthesis by binding to the terminal adenosine ribose (A76) of leucyl-tRNA synthetase.
V2104 Flavoxate sulfate 15301-69-6 Flavoxate sulfate (Rec-7-0040; DW61) is a potent anticholinergic (AChR) agent that binds and inhibits muscarinic receptors, thereby suppressing the micturition reflex and increases urinary bladder capacity by modifying the micturition center in the brain stem.
V3587 Foretinib-Based PROTAC 7 2230821-68-6 Foretinib-Based PROTAC 7 is a novel, potent and selective VHL-recruiting PROTAC that induces the degradation of c-Met in a dose- and time-dependent fashion in MDA-MB-231 cells.
V3897 Fosnetupitant 1703748-89-3 Fosnetupitant (07PNET; 07-PNET; Fosnetupitant chloride; Akynzeo), the prodrug of netupitant,is a novel and potentantagonist of neurokinin receptor usedin combination with palonosetron to prevent nausea and vomiting caused by chemotherapy.
V3507 Fosravuconazole 351227-64-0 Fosravuconazole (formerly known as E-1224, BEF-1224, and BMS-379224) is an azole-based antifungal agent that can be potentially used for the treatment of fungal infections.
V2128 GNE-0723 1883518-31-7 GNE 0723 is a novel, potent, brain permeable positive allosteric modulator (PAM) and GluN2A subunit-selective ofNMDAR, with anEC50of 21 nM for GluN2A, 7.4 and 6.2 μM for GluN2C and GluN2D, respectively.
V2125 GNE-207 2158266-58-9 GNE-207 is a novel, potent, selective and orally bioavailable inhibitor of the bromodomain ofCBP.
V2131 GNE-371 1926986-36-8 GNE-371 is a novel, potent and selective chemical probe for the second bromodomains of human transcription-initiation-factorTFIIDsubunit 1 and transcription-initiation-factorTFIIDsubunit 1-like with anIC50of 10 nM for TAF1(2).
V2126 GNE-493 1033735-94-2 GNE-493 is a novel, potent, selective, and orally bioavailable dualpan-PI3-kinase/mTORinhibitor withIC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR.
V2130 GNE-5729 2026635-66-3 GNE 5729 is a novel, potent, brain permeable positive allosteric modulator (PAM) and GluN2A subunit-selective ofNMDAR with anEC50of 37 nM for GluN2A, 4.7 and 9.5 μM for GluN2C and GluN2D, respectively.
V2123 GNE-6468 1677668-27-7 GNE-6468 is a novel, potent and selectiveRORγ (RORc)agonists with anEC50value of 13 nM in HEK-293 cells.
V2133 GNE684 GNE684 is a novel and potent inhibitor ofreceptor interacting protein 1 (RIP1), it inhibits human RIP1 potently over than mouse and rat withIC50s of 21 nM, 189 nM and 691 nM, respectively.
V2122 GNF179 1261114-01-5 GNF179, an optimized 8,8-dimethylimidazolopiperazine analog,is a novel, potent and orally bioavailable antiparasitic agent that exhibited the potency(4.8 nM against the multidrug resistant strain W2) in vitro metabolic stability and in vivo oral bioavailability.
V3539 GSK-269984A 892664-04-9 GSK-269984A is a novel and potentProstaglandin E2 Receptor 1 (EP1)antagonist with apIC50of 7.9.
V2062 GSK1379725A 1802251-00-8 GSK1379725A (AU1) is the first small molecule selective for BPTF over Brd4, as an inhibitor ofBrd4and a selective BPTF ligand with Kdof 2.8 μM.
V3592 GSK2973980A 1414797-35-5 GSK2973980A is a novel, potent and selective inhibitor ofAcyl-CoA:diacylglycerol acyltransferase 1 (DGAT1)with anIC50of 3 nM.
Contact Us Back to top